NRP1 and non-small cell lung carcinoma: To determine whether NRP1 could be a molecular therapeutic target or radiosensitizer in the treatment of NSCLC, we employed RNA interference technology to inhibit expression of the NRP1 gene and analyse the effect of NRP1 inhibition on growth, survival and radio-sensitivity of NSCLC cells.